Gurus BioPharm is a biotech startup developing innovative drugs based on prostaglandin modification by Nitric Oxide donor. Our pipeline includes first-in-class molecules for these the indication: 1. Alopecia (passed pilot clinical trials) 2. Asthma (ready for Phase I) 3. COPD (ready for Phase I) 4. Glaucoma (preclinical stage) 5. COVID-19 vasculopathy (discovery stage) 6. COVID-19 pneumonia (discovery stage) 7. Coronavirus and flu (discovery stage) 8. Cancer drug enhancer (discovery stage) 9. Pulmonary arterial hypertension (discovery stage) 10. Stroke (discovery stage) 11. Erectile dysfunction (discovery stage) 12. Critical Limb Ischemia (discovery stage)